Antibody Engineering & Therapeutics is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Brandon DeKosky is an assistant professor of Chemical Engineering and Pharmaceutical Chemistry and affiliated with the Kansas Vaccine Institute at the University of Kansas, and his research emphasis is in high-throughput analyses of antibody immune responses. Dr. DeKosky developed new technologies for sequencing complete antibody variable regions from single B cells during his Ph.D. in the lab of George Georgiou at the University of Texas at Austin. As a postdoc with John Mascola at the NIAID Vaccine Research Center, Dr. DeKosky applied high-throughput antibody sequencing and functional repertoire characterization to accelerate public health vaccine development. The DeKosky lab at KU leverages high-throughput platforms to understand the critical features of adaptive immune protection and to develop novel strategies to combat human diseases.